Please use this identifier to cite or link to this item:

TitleEffect of silver nanoparticles against Candida albicans and Candida glabrata biofilms
Author(s)Monteiro, D. R.
Silva, Sónia Carina
Negri, M.
Camargo, E. R.
Oliveira, Rosário
Henriques, Mariana
Barbosa, D. B.
Issue date2011
Abstract(s)Objectives: Fungal infections in immunocompromised patients have been contributing to the increasing morbidity and mortality of these patients, especially associated to yeast resistance to antifungal therapy. The increase in antibiotic-resistant microorganisms has prompted interest in the use of silver as an antimicrobial agent. Thus, the aim of this study was to evaluate the antifungal efficacy of silver nanoparticles against Candida albicans and Candida glabrata biofilms. Methods: Spherical nano-silver (average diameter 5nm) particles were synthesized by silver nitrate reduction with sodium citrate. Minimal inhibitory concentration (MIC) tests were performed for C. albicans (n=2) and C. glabrata (n=2) grown in suspension using the microbroth dilution method. Silver nanoparticles were applied on adhered cells (2 h) or biofilms (48 h) and after 24h biofilms were characterized by colony forming units (CFUs) enumeration and total biomass quantification (using crystal violet staining). Results: Interestingly, C. glabrata MIC values were higher (0.4 – 3.3 µg/mL) than C. albicans (0.4 – 1.6 µg/mL). Furthermore, the results obtained revealed that silver nanoparticles were more effective in reducing 24h biofilms' biomass when applied onto adhered cells (2h) than on pre-formed biofilms (48h), with the exception of C. glabrata clinical isolate, which in both cases had a reduction around 90%. Regarding cell viability, silver nanoparticles were highly effective on adhered C. glabrata (reduction of around 70%) and respective biofilms (reduction of around 50%). On C. albicans the effect was not so notorious but there was also a reduction on the number of biofilm viable cells. Conclusion: Silver nanoparticles have great potential to be an effective alternative to antifungal agents for future therapies in Candida infections.
AccessOpen access
Appears in Collections:CEB - Resumos em Livros de Atas / Abstracts in Proceedings

Files in This Item:
File Description SizeFormat 
PDF1 6.pdf376,23 kBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID